Avita Medical Inc, is a medical device company with a technology platform in place to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company’s lead product is RECELL System, a single use (disposable) stand-alone, battery operated device approved for the treatment of acute thermal burns in adult patients. The device prepares Regenerative Epidermal Suspension that helps to regenerate natural and healthy epidermis. The company has operations in the US, Australia and the UK. Avita Medical Inc is headquartered in Valencia, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avita Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Avita Medical Inc Company Overview
- Avita Medical Inc Company Snapshot
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc - Pipeline Analysis Overview
- Business Description
- Avita Medical Inc - Key Facts
- Avita Medical Inc - Major Products and Services
- Avita Medical Inc Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Overview
- ReCell - Diabetic Foot Ulcers
- ReCell - Diabetic Foot Ulcers Product Overview
- Recell - Epidermolysis Bullosa
- Recell - Epidermolysis Bullosa Product Overview
- Recell - Hutchinson-Gilford Progeria Syndrome
- Recell - Hutchinson-Gilford Progeria Syndrome Product Overview
- ReCell - Skin Rejuvenation
- ReCell - Skin Rejuvenation Product Overview
- RECELL - Soft Tissue Reconstruction
- RECELL - Soft Tissue Reconstruction Product Overview
- ReCell - Trauma Wounds
- ReCell - Trauma Wounds Product Overview
- ReCell - Venous Leg Ulcers
- ReCell - Venous Leg Ulcers Product Overview
- ReCell Go - Acute Wounds
- ReCell Go - Acute Wounds Product Overview
- Avita Medical Inc - Key Competitors
- Avita Medical Inc - Key Employees
- Avita Medical Inc - Key Employee Biographies
- Avita Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Avita Medical Inc, Recent Developments
- Apr 13, 2023: AVITA Medical announces update to automation device
- Dec 14, 2021: AVITA Medical Announces Adjournment of 2021 Annual Stockholder Meeting
- Sep 13, 2021: AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference
- Jun 15, 2021: AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results
- Jun 01, 2021: AVITA Medical Appoints Two New Non-Executive Members to the Board of Directors
- Mar 22, 2021: AVITA Medical names Michael Holder as Chief Financial Officer
- Feb 18, 2021: AVITA Medical to Present at Upcoming Investor Conferences
- Feb 11, 2021: AVITA Medical Reports Full Second Quarter 2021 Financial Results
- Jan 28, 2021: AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results
- Nov 03, 2020: AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference Call
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Indication
- Avita Medical Inc, Key Facts
- Avita Medical Inc, Major Products and Services
- Avita Medical Inc Number of Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Summary by Development Stage
- ReCell - Diabetic Foot Ulcers - Product Status
- ReCell - Diabetic Foot Ulcers - Product Description
- Recell - Epidermolysis Bullosa - Product Status
- Recell - Epidermolysis Bullosa - Product Description
- Recell - Hutchinson-Gilford Progeria Syndrome - Product Status
- Recell - Hutchinson-Gilford Progeria Syndrome - Product Description
- ReCell - Skin Rejuvenation - Product Status
- ReCell - Skin Rejuvenation - Product Description
- RECELL - Soft Tissue Reconstruction - Product Status
- RECELL - Soft Tissue Reconstruction - Product Description
- ReCell - Trauma Wounds - Product Status
- ReCell - Trauma Wounds - Product Description
- ReCell - Venous Leg Ulcers - Product Status
- ReCell - Venous Leg Ulcers - Product Description
- ReCell Go - Acute Wounds - Product Status
- ReCell Go - Acute Wounds - Product Description
- Avita Medical Inc, Key Employees
- Avita Medical Inc, Key Employee Biographies
- Avita Medical Inc, Other Locations
- Avita Medical Inc, Subsidiaries
- Avita Medical Inc, Joint Venture
- Glossary
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mallinckrodt Plc
- Vericel Corp
- Organogenesis Holdings Inc
- Pfizer SA de CV
- Smith & Nephew Plc
- Johnson & Johnson
